glp 1 agonist trials The transformative breakthroughs in GLP-1 research recognized by the 2024 Lasker~DeBakey award | Current Medicine GLP-1 receptor agonists are increasingly
Description
Exogenous glucagon-like peptide 1 reduces contractions in human colon circular muscle
The practical takeaway is that high-polyphenol EVOO is best understood as a metabolic tool within a whole-diet context, not as a standalone weight-loss agent
In the SURMOUNT-1 trial, tirzepatide 15 mg weekly achieved 20.9% WL over 72 weeks (vs
One design released semaglutide in "pulses" over a month from a single patch, mimicking multiple weekly injections in an animal model
We first reported that the internalization of GLP-1 is compromised in the presence of GIPR full agonist IUB68 (22)
